Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v4-FR
Language French French
Date Updated 2020-02-20 2020-02-20
Drug Identification Number 02242811 02242811
Brand name SCOPOLAMINE HYDROBROMIDE INJECTION SCOPOLAMINE HYDROBROMIDE INJECTION
Common or Proper name Scopolamine Hydrobromide Injection Scopolamine Hydrobromide Injection
Company Name OMEGA LABORATORIES LIMITED OMEGA LABORATORIES LIMITED
Ingredients SCOPOLAMINE HYDROBROMIDE SCOPOLAMINE HYDROBROMIDE
Strength(s) 0.6MG 0.6MG
Dosage form(s) LIQUID LIQUID
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 10 x 1mL vial /fiole 10 x 1mL vial /fiole
ATC code N05CM N05CM
ATC description HYPNOTICS AND SEDATIVES HYPNOTICS AND SEDATIVES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-17 2020-01-17
Estimated end date 2020-01-31 2020-01-31
Actual end date 2020-02-14 2020-02-14
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments